Reaction
Bronchopleural Fistula reporting signals
As of the last recalculation, Bronchopleural Fistula appears in 374 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is REMDESIVIR (PRR 131.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Remdesivir | 29 | 131.2 | 131.5 |
| Oseltamivir | 7 | 49.8 | 49.9 |
| Ceftriaxone | 21 | 37.7 | 37.7 |
| Ganciclovir Sodium | 7 | 37.5 | 37.5 |
| Meropenem | 20 | 36.6 | 36.6 |
| Pemetrexed | 11 | 29.4 | 29.4 |
| Paclitaxel (Aibumin-Bound) | 37 | 27.7 | 27.7 |
| Paclitaxel | 38 | 23.7 | 23.7 |
| Pemetrexed Disodium | 14 | 21.2 | 21.2 |
| Gefitinib | 3 | 18.6 | 18.6 |
| Durvalumab | 6 | 16.7 | 16.7 |